Veea and NovaGen Announce Merger to Launch AI-Powered Global Health Platform

Key Facts

In a move reflecting the growing trend of integrating artificial intelligence into the healthcare sector, Veea Inc. and NovaGen Group B.V. have announced a potential merger to launch an advanced global health platform. According to reports, this partnership will combine Veea's edge computing and cybersecurity infrastructure with NovaGen's expertise in cellular reprogramming science and clinical services. The combined entity aims to provide AI-driven health solutions that empower individuals to control their medical data and link it with wearable biometric measurements.

Internal projections and independent valuations suggest the combined company's value is approximately $750 million, with GeoNova Capital committing an initial $10 million investment as part of the deal. Initial deployments of the new platform are scheduled to begin at NovaGen clinics and partner hospitals in Q4 2026. This news comes as technology startups increasingly seek to strengthen their presence in public markets through strategic mergers that provide clear growth paths.

Regarding stock performance, VEEA closed at $1.56 (close September 11, 2026), with a daily trading range between $1.53 and $1.65 per market data. Investors should monitor upcoming developments regarding the execution of the definitive business combination agreement in the coming weeks, keeping in mind that the company also announced a 1-for-20 reverse stock split.